uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Efficacy, Safety and Pharmacokinetic Results from a Phase II Study of Pasireotide (SOM230) in the Treatment of Patients with Metastatic NETs Refractory or Resistant to Octreotide LAR
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
2010 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 92, no 1, 42-43 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2010. Vol. 92, no 1, 42-43 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-138361OAI: oai:DiVA.org:uu-138361DiVA: diva2:379315
Available from: 2010-12-17 Created: 2010-12-17 Last updated: 2011-04-19Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Medical Sciences
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 114 hits
ReferencesLink to record
Permanent link

Direct link